Clinical Trial

DCGI Approves Phase II/III Clinical Trial of COVAXIN Among Age Group of 2 to 18 Years

Bharat Biotech International Ltd., Hyderabad (BBIL) had proposed to carry out a Phase- II/III clinical trial of Covaxin in the…

Read More »